ANN ARBOR, Mich., June 16, 2025--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in imaging technologies for the early detection and monitoring of metabolic liver disease, today ...
ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard Refinements to probe configuration and proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results